Source: Eur Respir J 2006; 27: 822-832
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jones P. W., Agusti A. G. N.. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 822-832

Member's Comments

No comment yet.

Related content which might interest you: Population surveillance in North West Adelaide: lung function and chronic obstructive pulmonary disease (COPD) across the diabetes spectrum Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 Is Hoover‘s sign helpful to detect expiratory flow limitation in chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Hoover‘s sign predicts expiratory flow limitation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 807s Year: 2006 The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 212s Year: 2005 Prognostic value of exercise testing Source: Annual Congress 2007 - PG12 - Cardiopulmonary exercise testing and interpretation Year: 2007 Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Definition and differential diagnosis of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1 Year: 2006 The minimal important difference of exercise tests in severe COPD Source: Eur Respir J 2011; 37: 784-790 Year: 2011 Determinants of success Source: Eur Respir J 2011; 38: 1215-1218 Year: 2011 Assessment of expiratory flow limitation in chronic obstructive pulmonary disease: a new approach Source: Eur Respir J 2004; 23: 187-188 Year: 2004 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Forced inspiratory volume in one second (FIV1) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002 Regional ventilatory defects in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2006 - COPD: imaging and computer applications Year: 2006 Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 The assessment of exercise capacity in chronic obstructive pulmonary disease patients Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 The natural history of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=71 Year: 2006 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Exercise capacity predicts survival in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 488s Year: 2001